Driving Efficiencies in Drug Development and Manufacturing

Investment in technology is driving the digital transformation of pharma and biotech business operations in key areas such as drug discovery, clinical trials and manufacturing. As companies become more dependent on technology, successfully procuring and integrating advanced applications will be a top priority for decision-makers, but without the right guidance they risk wasting a lot of resources.  

This webinar – hosted by the Financial Times in partnership with Infosys – explored how pharma and biotech firms are attempting to unlock efficiencies by digitising, simplifying and connecting systems, processes and data. It will look at how they are overcoming hurdles, such as investing in new and emerging skills, finding new partners, and reshaping internal practices to develop a digital-first mindset. It will also evaluate how to create a strategic road map for a successful transformation process.  

Digital Transformation

How is digital transformation reshaping the operational and business models of the industry? How do you create a blueprint for the deployment of a transformation programme? 

Emerging Technologies

Which emerging technologies look most appealing to pharma and biotech firms? How can pharma and biotech firms deliver pioneering treatments at speed and scale, with reduced cycle times? 

Strategic Collaboration

Why is strategic collaboration between major pharma firms and startups important? What steps can be taken to connect people, processes and data? 

FT Live Digital Dialogues - fully digital 50 minute event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice